diclofenac has been researched along with thromboplastin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buerkle, MA; Hellwig, N; Klauss, V; Krötz, F; Mannell, H; Pircher, J; Pohl, U; Sohn, HY; Struthmann, L | 1 |
| Abdulmalek, S; Abu Alrub, H; El Azab, EF; Elfaki, EM; Hamza, A; Mazhari, BBZ; Saleh, AM; Yousif, SO | 1 |
2 other study(ies) available for diclofenac and thromboplastin
| Article | Year |
|---|---|
Prothrombotic effects of diclofenac on arteriolar platelet activation and thrombosis in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arterioles; Cells, Cultured; Chlorides; Cricetinae; Cyclooxygenase Inhibitors; Diclofenac; Endothelium, Vascular; Ferric Compounds; Humans; Mesocricetus; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Platelet Activation; Platelet Adhesiveness; Skin Window Technique; Thromboplastin; Thrombosis; Thromboxane B2; Tumor Necrosis Factor-alpha | 2009 |
New insights into geraniol's antihemolytic, anti-inflammatory, antioxidant, and anticoagulant potentials using a combined biological and in silico screening strategy.
Topics: Acyclic Monoterpenes; Animals; Anti-Inflammatory Agents; Anticoagulants; Antioxidants; Chlorides; Diclofenac; Hemolysis; Humans; Inflammation; Interleukin-10; Interleukin-8; Lipopolysaccharides; Malondialdehyde; MAP Kinase Kinase Kinase 5; Molecular Docking Simulation; Nitric Oxide; Rats; Superoxide Dismutase; Thromboplastin; Tumor Necrosis Factor-alpha | 2022 |